Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

ELAB vs DBVT vs ALKS vs HOFV

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ELAB
PMGC Holdings Inc.

Biotechnology

HealthcareNASDAQ • US
Market Cap$49K
5Y Perf.-100.0%
DBVT
DBV Technologies S.A.

Biotechnology

HealthcareNASDAQ • FR
Market Cap$1712.35T
5Y Perf.+166.6%
ALKS
Alkermes plc

Biotechnology

HealthcareNASDAQ • IE
Market Cap$5.90B
5Y Perf.+44.9%
HOFV
Hall of Fame Resort & Entertainment Company

Entertainment

Communication ServicesNASDAQ • US
Market Cap$2M
5Y Perf.-90.4%

ELAB vs DBVT vs ALKS vs HOFV — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ELAB logoELAB
DBVT logoDBVT
ALKS logoALKS
HOFV logoHOFV
IndustryBiotechnologyBiotechnologyBiotechnologyEntertainment
Market Cap$49K$1712.35T$5.90B$2M
Revenue (TTM)$-1M$0.00$1.56B$17M
Net Income (TTM)$-7M$-168M$153M$-63M
Gross Margin72.8%65.4%63.0%
Operating Margin-75.7%12.3%-158.0%
Forward P/E24.8x
Total Debt$0.00$22M$70M$249M
Cash & Equiv.$4M$194M$1.12B$432K

ELAB vs DBVT vs ALKS vs HOFVLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ELAB
DBVT
ALKS
HOFV
StockNov 23May 26Return
PMGC Holdings Inc. (ELAB)1000.0-100.0%
DBV Technologies S.… (DBVT)100266.6+166.6%
Alkermes plc (ALKS)100144.9+44.9%
Hall of Fame Resort… (HOFV)1009.6-90.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: ELAB vs DBVT vs ALKS vs HOFV

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ALKS leads in 3 of 6 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. PMGC Holdings Inc. is the stronger pick specifically for growth and revenue expansion. DBVT also leads in specific categories worth noting. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
ELAB
PMGC Holdings Inc.
The Growth Play

ELAB is the #2 pick in this set and the best alternative if growth exposure is your priority.

  • Rev growth 44.1%, EPS growth 86.0%, 3Y rev CAGR 13.4%
  • 44.1% revenue growth vs DBVT's -100.0%
Best for: growth exposure
DBVT
DBV Technologies S.A.
The Income Pick

DBVT is the clearest fit if your priority is income & stability.

  • Dividend streak 0 yrs, beta 1.26
  • +110.4% vs ELAB's -99.7%
Best for: income & stability
ALKS
Alkermes plc
The Long-Run Compounder

ALKS carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.

  • -11.0% 10Y total return vs DBVT's -87.0%
  • Lower volatility, beta 1.06, Low D/E 3.8%, current ratio 3.55x
  • Beta 1.06, current ratio 3.55x
  • 9.8% margin vs HOFV's -366.2%
Best for: long-term compounding and sleep-well-at-night
HOFV
Hall of Fame Resort & Entertainment Company
The Lower-Volatility Pick

HOFV lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: communication services exposure
See the full category breakdown
CategoryWinnerWhy
GrowthELAB logoELAB44.1% revenue growth vs DBVT's -100.0%
Quality / MarginsALKS logoALKS9.8% margin vs HOFV's -366.2%
Stability / SafetyALKS logoALKSBeta 1.06 vs ELAB's 4.01
DividendsTieNone of these 4 stocks pay a meaningful dividend
Momentum (1Y)DBVT logoDBVT+110.4% vs ELAB's -99.7%
Efficiency (ROA)ALKS logoALKS5.4% ROA vs DBVT's -89.0%

ELAB vs DBVT vs ALKS vs HOFV — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ELABPMGC Holdings Inc.

Segment breakdown not available.

DBVTDBV Technologies S.A.

Segment breakdown not available.

ALKSAlkermes plc
FY 2025
Vivitrol
39.8%$468M
Aristada And Aristada Initio
31.5%$370M
Manufactured Product And Royalty
24.8%$291M
Manufacturing Revenue
3.9%$46M
HOFVHall of Fame Resort & Entertainment Company

Segment breakdown not available.

ELAB vs DBVT vs ALKS vs HOFV — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLALKSLAGGINGHOFV

Income & Cash Flow (Last 12 Months)

ALKS leads this category, winning 4 of 6 comparable metrics.

ALKS and ELAB operate at a comparable scale, with $1.6B and -$1M in trailing revenue. ALKS is the more profitable business, keeping 9.8% of every revenue dollar as net income compared to HOFV's -3.7%. On growth, ALKS holds the edge at +28.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricELAB logoELABPMGC Holdings Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcHOFV logoHOFVHall of Fame Reso…
RevenueTrailing 12 months-$1M$0$1.6B$17M
EBITDAEarnings before interest/tax-$4M-$112M$212M-$10M
Net IncomeAfter-tax profit-$7M-$168M$153M-$63M
Free Cash FlowCash after capex-$7M-$151M$392M-$11M
Gross MarginGross profit ÷ Revenue+72.8%+65.4%+63.0%
Operating MarginEBIT ÷ Revenue-75.7%+12.3%-158.0%
Net MarginNet income ÷ Revenue-2.5%+9.8%-3.7%
FCF MarginFCF ÷ Revenue-2.2%+25.1%-64.5%
Rev. Growth (YoY)Latest quarter vs prior year-45.8%+28.2%-33.3%
EPS Growth (YoY)Latest quarter vs prior year+100.0%+91.5%-4.1%-2.0%
ALKS leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

ELAB leads this category, winning 2 of 3 comparable metrics.
MetricELAB logoELABPMGC Holdings Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcHOFV logoHOFVHall of Fame Reso…
Market CapShares × price$49,114$1712.35T$5.9B$2M
Enterprise ValueMkt cap + debt − cash-$4M$1712.35T$4.9B$251M
Trailing P/EPrice ÷ TTM EPS-0.01x-0.76x24.76x-0.04x
Forward P/EPrice ÷ next-FY EPS est.
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple17.25x
Price / SalesMarket cap ÷ Revenue0.02x4.00x0.11x
Price / BookPrice ÷ Book value/share0.01x0.66x3.28x0.03x
Price / FCFMarket cap ÷ FCF12.28x
ELAB leads this category, winning 2 of 3 comparable metrics.

Profitability & Efficiency

ALKS leads this category, winning 8 of 9 comparable metrics.

ALKS delivers a 8.8% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-2 for HOFV. ALKS carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to HOFV's 3.45x. On the Piotroski fundamental quality scale (0–9), ALKS scores 7/9 vs HOFV's 3/9, reflecting strong financial health.

MetricELAB logoELABPMGC Holdings Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcHOFV logoHOFVHall of Fame Reso…
ROE (TTM)Return on equity-78.4%-130.2%+8.8%-2.1%
ROA (TTM)Return on assets-44.6%-89.0%+5.4%-17.6%
ROICReturn on invested capital-82.7%+18.9%-6.7%
ROCEReturn on capital employed-33.7%-145.7%+14.2%-7.9%
Piotroski ScoreFundamental quality 0–94473
Debt / EquityFinancial leverage0.13x0.04x3.45x
Net DebtTotal debt minus cash-$4M-$172M-$1.0B$249M
Cash & Equiv.Liquid assets$4M$194M$1.1B$432,174
Total DebtShort + long-term debt$0$22M$70M$249M
Interest CoverageEBIT ÷ Interest expense-17.68x-189.82x32.30x-1.04x
ALKS leads this category, winning 8 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — DBVT and ALKS each lead in 3 of 6 comparable metrics.

A $10,000 investment in ALKS five years ago would be worth $16,091 today (with dividends reinvested), compared to $0 for ELAB. Over the past 12 months, DBVT leads with a +110.4% total return vs ELAB's -99.7%. The 3-year compound annual growth rate (CAGR) favors DBVT at 6.2% vs ELAB's -98.7% — a key indicator of consistent wealth creation.

MetricELAB logoELABPMGC Holdings Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcHOFV logoHOFVHall of Fame Reso…
YTD ReturnYear-to-date-98.4%+4.9%+25.3%0.0%
1-Year ReturnPast 12 months-99.7%+110.4%+16.5%-50.0%
3-Year ReturnCumulative with dividends-100.0%+19.7%+14.5%-95.0%
5-Year ReturnCumulative with dividends-100.0%-69.1%+60.9%-99.5%
10-Year ReturnCumulative with dividends-100.0%-87.0%-11.0%-99.8%
CAGR (3Y)Annualised 3-year return-98.7%+6.2%+4.6%-63.1%
Evenly matched — DBVT and ALKS each lead in 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — ALKS and HOFV each lead in 1 of 2 comparable metrics.

HOFV is the less volatile stock with a -0.48 beta — it tends to amplify market swings less than ELAB's 4.01 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALKS currently trades 96.7% from its 52-week high vs ELAB's 0.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricELAB logoELABPMGC Holdings Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcHOFV logoHOFVHall of Fame Reso…
Beta (5Y)Sensitivity to S&P 5003.94x1.26x1.00x-0.62x
52-Week HighHighest price in past year$1236.48$26.18$36.60$0.90
52-Week LowLowest price in past year$1.62$7.53$25.17$0.24
% of 52W HighCurrent price vs 52-week peak+0.2%+76.3%+96.7%+38.9%
RSI (14)Momentum oscillator 0–10036.748.160.243.5
Avg Volume (50D)Average daily shares traded10.4M252K2.3M0
Evenly matched — ALKS and HOFV each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Analyst consensus: DBVT as "Buy", ALKS as "Buy". Consensus price targets imply 131.8% upside for DBVT (target: $46) vs 29.9% for ALKS (target: $46).

MetricELAB logoELABPMGC Holdings Inc.DBVT logoDBVTDBV Technologies …ALKS logoALKSAlkermes plcHOFV logoHOFVHall of Fame Reso…
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$46.33$46.00
# AnalystsCovering analysts1528
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises000
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%+0.5%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

ALKS leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ELAB leads in 1 (Valuation Metrics). 2 tied.

Best OverallAlkermes plc (ALKS)Leads 2 of 6 categories
Loading custom metrics...

ELAB vs DBVT vs ALKS vs HOFV: Key Questions Answered

8 questions · data-driven answers · updated daily

01

Is ELAB or DBVT or ALKS or HOFV a better buy right now?

For growth investors, PMGC Holdings Inc.

(ELAB) is the stronger pick with 44. 1% revenue growth year-over-year, versus -12. 1% for Hall of Fame Resort & Entertainment Company (HOFV). Alkermes plc (ALKS) offers the better valuation at 24. 8x trailing P/E, making it the more compelling value choice. Analysts rate DBV Technologies S. A. (DBVT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — ELAB or DBVT or ALKS or HOFV?

Over the past 5 years, Alkermes plc (ALKS) delivered a total return of +60.

9%, compared to -100. 0% for PMGC Holdings Inc. (ELAB). Over 10 years, the gap is even starker: ALKS returned -12. 0% versus ELAB's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — ELAB or DBVT or ALKS or HOFV?

By beta (market sensitivity over 5 years), Hall of Fame Resort & Entertainment Company (HOFV) is the lower-risk stock at -0.

62β versus PMGC Holdings Inc. 's 3. 94β — meaning ELAB is approximately -736% more volatile than HOFV relative to the S&P 500. On balance sheet safety, Alkermes plc (ALKS) carries a lower debt/equity ratio of 4% versus 3% for Hall of Fame Resort & Entertainment Company — giving it more financial flexibility in a downturn.

04

Which is growing faster — ELAB or DBVT or ALKS or HOFV?

By revenue growth (latest reported year), PMGC Holdings Inc.

(ELAB) is pulling ahead at 44. 1% versus -12. 1% for Hall of Fame Resort & Entertainment Company (HOFV). On earnings-per-share growth, the picture is similar: PMGC Holdings Inc. grew EPS 86. 0% year-over-year, compared to -347. 5% for DBV Technologies S. A.. Over a 3-year CAGR, ELAB leads at 1340% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — ELAB or DBVT or ALKS or HOFV?

Alkermes plc (ALKS) is the more profitable company, earning 16.

4% net margin versus -263. 4% for Hall of Fame Resort & Entertainment Company — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALKS leads at 17. 2% versus -139. 9% for HOFV. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — ELAB or DBVT or ALKS or HOFV?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

07

Is ELAB or DBVT or ALKS or HOFV better for a retirement portfolio?

For long-horizon retirement investors, Hall of Fame Resort & Entertainment Company (HOFV) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.

62)). PMGC Holdings Inc. (ELAB) carries a higher beta of 3. 94 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HOFV: -99. 8%, ELAB: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between ELAB and DBVT and ALKS and HOFV?

These companies operate in different sectors (ELAB (Healthcare) and DBVT (Healthcare) and ALKS (Healthcare) and HOFV (Communication Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ELAB is a small-cap high-growth stock; DBVT is a mega-cap quality compounder stock; ALKS is a small-cap quality compounder stock; HOFV is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

ELAB

Quality Business

  • Sector: Healthcare
  • Market Cap > $2B
  • Gross Margin > 43%
Run This Screen
Stocks Like

DBVT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

ALKS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Net Margin > 5%
Run This Screen
Stocks Like

HOFV

Quality Business

  • Sector: Communication Services
  • Market Cap > $100B
  • Gross Margin > 37%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.